Vox Markets podcast featuring an interview with Dr Navid Malik Executive Director at The Life Sciences Division – Sept 2019

16th September 2019 - 12:43 pm

Dr Navid Malik Executive Director at The Life Sciences Division provides on outlook on ImmuPharma (IMM) and its flagship drug Lupuzor, a treatment for autoimmune disease Lupus.

Share this article